Mycobacterium tuberculosis and SARS-CoV-2 Co-Infection: An Efficient Cell Model to Study Lung Host-Pathogen...

Area of Science:

• Infectious Diseases
• Cell Biology
• Respiratory Medicine

Background:

• SARS-CoV-2 rapidly became a leading cause of death, impacting the respiratory system.
• Mycobacterium tuberculosis (Mtb) also primarily affects the lungs.
• The effects of Mtb and SARS-CoV-2 co-infection on host response remain largely unknown.

Purpose of the Study:

• To develop a rigorous in vitro system for evaluating Mtb and SARS-CoV-2 co-infection.
• To study the complex interactions between simultaneous respiratory pathogen infections.
• To provide a standardized protocol for experimentalists.

Main Methods:

• Establishment of an in vitro model using the A549 human lung epithelial cell line.
• Detailed eight-step protocol including pathogen culture, cell maintenance, and infection procedures.
• Quantification of intracellular bacterial load and viral viability.

Main Results:

• A comprehensive protocol for in vitro co-infection with Mtb and SARS-CoV-2 was established.
• The system allows for the evaluation of simultaneous infections in lung epithelial cells.
• Optional validation assays for infectivity reduction were included.

Conclusions:

• This protocol facilitates the study of Mtb and SARS-CoV-2 co-infection pathogenesis in vitro.
• The model supports collaborative research on dual respiratory infections.
• Enables detailed investigation into the complex interactions of simultaneous infections.